The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration: a MACUSTAR study report

Introduction: There is an unmet medical need for therapies in intermediate age-related macular degeneration (iAMD). The prospective European multicenter cohort study MACUSTAR validates structural, functional, and patient-reported iAMD endpoints for use in future trials. The multiplicity of assessmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Terheyden, Jan H. (VerfasserIn) , Holz, Frank G. (VerfasserIn) , Behning, Charlotte (VerfasserIn) , Dunbar, Hannah M.P. (VerfasserIn) , Schmitz-Valckenberg, Steffen (VerfasserIn) , Tufail, Adnan (VerfasserIn) , Schmid, Matthias (VerfasserIn) , Crabb, David P. (VerfasserIn) , Saßmannshausen, Marlene (VerfasserIn) , Binns, Alison (VerfasserIn) , Hoyng, Carel B. (VerfasserIn) , Zakaria, Nadia (VerfasserIn) , Poor, Stephen (VerfasserIn) , Moll, Klaus-Peter (VerfasserIn) , Cosette, Deborah (VerfasserIn) , Martinho, Cecília (VerfasserIn) , Batuca, Joana (VerfasserIn) , Cunha-Vaz, José (VerfasserIn) , Luhmann, Ulrich F.O. (VerfasserIn) , Leal, Sergio (VerfasserIn) , Finger, Robert P. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2025
In: Ophthalmologica
Year: 2025, Jahrgang: 248, Heft: 2, Pages: 101-111
ISSN:1423-0267
DOI:10.1159/000543231
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1159/000543231
Volltext
Verfasserangaben:Jan Henrik Terheyden, Frank G. Holz, Charlotte Behning, Hannah M.P. Dunbar, Steffen Schmitz-Valckenberg, Adnan Tufail, Matthias Schmid, David P. Crabb, Marlene Saßmannshausen, Alison Binns, Carel B. Hoyng, Nadia Zakaria, Stephen Poor, Klaus-Peter Moll, Deborah Cosette, Cecília Martinho, Joana Batuca, José Cunha-Vaz, Ulrich F.O. Luhmann, Sergio Leal, Robert P. Finger, on behalf of the MACUSTAR consortium

MARC

LEADER 00000naa a2200000 c 4500
001 1929396309
003 DE-627
005 20250701093224.0
007 cr uuu---uuuuu
008 250701s2025 xx |||||o 00| ||eng c
024 7 |a 10.1159/000543231  |2 doi 
035 |a (DE-627)1929396309 
035 |a (DE-599)KXP1929396309 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Terheyden, Jan H.  |d 1991-  |e VerfasserIn  |0 (DE-588)1155799992  |0 (DE-627)1018201106  |0 (DE-576)501890114  |4 aut 
245 1 4 |a The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration  |b a MACUSTAR study report  |c Jan Henrik Terheyden, Frank G. Holz, Charlotte Behning, Hannah M.P. Dunbar, Steffen Schmitz-Valckenberg, Adnan Tufail, Matthias Schmid, David P. Crabb, Marlene Saßmannshausen, Alison Binns, Carel B. Hoyng, Nadia Zakaria, Stephen Poor, Klaus-Peter Moll, Deborah Cosette, Cecília Martinho, Joana Batuca, José Cunha-Vaz, Ulrich F.O. Luhmann, Sergio Leal, Robert P. Finger, on behalf of the MACUSTAR consortium 
264 1 |c April 2025 
300 |b Illustrationen, Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 3. Februar 2025 
500 |a Gesehen am 01.07.2025 
520 |a Introduction: There is an unmet medical need for therapies in intermediate age-related macular degeneration (iAMD). The prospective European multicenter cohort study MACUSTAR validates structural, functional, and patient-reported iAMD endpoints for use in future trials. The multiplicity of assessments allows characterizing iAMD in more dimensions than previously available. We describe the heterogeneity of assessments in the iAMD baseline cohort of the MACUSTAR study. Methods: A wide range of assessments was administered across 20 European study sites in accordance with established guidelines. These assessments encompassed multiple structural evaluations, such as color fundus photography, fundus autofluorescence, and optical coherence tomography. Additionally, functional tests were conducted, including assessments of best-corrected and low-luminance visual acuity (VA), Moorfields acuity, contrast sensitivity, reading speed, mesopic and scotopic microperimetry, and dark adaptometry. Moreover, patient-reported outcome assessments, specifically the Vision Impairment in Low Luminance questionnaire, were also incorporated into the evaluation process. Associations between variables were investigated using Phi coefficients, Pearson correlation coefficients and age-corrected regression models. Results: Five-hundred eighty-five individuals with iAMD (66% women; mean (standard deviation) age: 72 ± 7 years) were included in the MACUSTAR study. Forty-nine percent had pigmentary abnormalities, 27% had reticular pseudodrusen; 10% and 9% had incomplete and complete retinal pigment epithelium and outer retinal atrophy at baseline, respectively. Mean best-corrected VA, low-luminance VA and mesopic average threshold on microperimetry at baseline were 0.03 ± 0.11 logMAR, 0.24 ± 0.16 logMAR, and 23.3 ± 3.7 dB. Mean Vision Impairment in Low Luminance (VILL) subscale scores at baseline were 2 ± 2 to 2 ± 3 logits. Phi coefficients between structural assessments ranged between 0.17 and 0.22 (median 0.21); correlation coefficients between function tests ranged between 0.07 and 0.69 (median 0.34) and between VILL scores ranged between 0.21 and 0.68 (median 0.23). Conclusion: The findings from this broad and comprehensive spectrum of assessments of structure, function, and patient-reported outcomes in iAMD suggest that the disease spectrum is diverse and heterogeneous and that further efforts are necessary to fully understand and characterize iAMD in all its complexities. A further in-depth characterization will enable novel enrichment strategies for clinical trials in iAMD. 
700 1 |a Holz, Frank G.  |e VerfasserIn  |4 aut 
700 1 |a Behning, Charlotte  |e VerfasserIn  |4 aut 
700 1 |a Dunbar, Hannah M.P.  |e VerfasserIn  |4 aut 
700 1 |a Schmitz-Valckenberg, Steffen  |e VerfasserIn  |4 aut 
700 1 |a Tufail, Adnan  |e VerfasserIn  |4 aut 
700 1 |a Schmid, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Crabb, David P.  |e VerfasserIn  |4 aut 
700 1 |a Saßmannshausen, Marlene  |e VerfasserIn  |4 aut 
700 1 |a Binns, Alison  |e VerfasserIn  |4 aut 
700 1 |a Hoyng, Carel B.  |e VerfasserIn  |4 aut 
700 1 |a Zakaria, Nadia  |e VerfasserIn  |4 aut 
700 1 |a Poor, Stephen  |e VerfasserIn  |4 aut 
700 1 |a Moll, Klaus-Peter  |e VerfasserIn  |4 aut 
700 1 |a Cosette, Deborah  |e VerfasserIn  |4 aut 
700 1 |a Martinho, Cecília  |e VerfasserIn  |4 aut 
700 1 |a Batuca, Joana  |e VerfasserIn  |4 aut 
700 1 |a Cunha-Vaz, José  |e VerfasserIn  |4 aut 
700 1 |a Luhmann, Ulrich F.O.  |e VerfasserIn  |4 aut 
700 1 |a Leal, Sergio  |e VerfasserIn  |4 aut 
700 1 |a Finger, Robert P.  |d 1979-  |e VerfasserIn  |0 (DE-588)133279049  |0 (DE-627)539656488  |0 (DE-576)287511855  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmologica  |d Basel : Karger, 1938  |g 248(2025), 2 vom: Apr., Seite 101-111  |h Online-Ressource  |w (DE-627)300897391  |w (DE-600)1483531-9  |w (DE-576)276271181  |x 1423-0267  |7 nnas  |a The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration a MACUSTAR study report 
773 1 8 |g volume:248  |g year:2025  |g number:2  |g month:04  |g pages:101-111  |g extent:11  |a The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration a MACUSTAR study report 
856 4 0 |u https://doi.org/10.1159/000543231  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250701 
993 |a Article 
994 |a 2025 
998 |g 133279049  |a Finger, Robert P.  |m 133279049:Finger, Robert P.  |d 60000  |d 61700  |e 60000PF133279049  |e 61700PF133279049  |k 0/60000/  |k 1/60000/61700/  |p 21  |y j 
999 |a KXP-PPN1929396309  |e 4740917440 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Terheyden, Jan H.","family":"Terheyden","role":"aut","given":"Jan H."},{"display":"Holz, Frank G.","family":"Holz","given":"Frank G.","role":"aut"},{"family":"Behning","display":"Behning, Charlotte","role":"aut","given":"Charlotte"},{"role":"aut","given":"Hannah M.P.","display":"Dunbar, Hannah M.P.","family":"Dunbar"},{"given":"Steffen","role":"aut","display":"Schmitz-Valckenberg, Steffen","family":"Schmitz-Valckenberg"},{"given":"Adnan","role":"aut","display":"Tufail, Adnan","family":"Tufail"},{"given":"Matthias","role":"aut","display":"Schmid, Matthias","family":"Schmid"},{"role":"aut","given":"David P.","family":"Crabb","display":"Crabb, David P."},{"display":"Saßmannshausen, Marlene","family":"Saßmannshausen","role":"aut","given":"Marlene"},{"role":"aut","given":"Alison","family":"Binns","display":"Binns, Alison"},{"given":"Carel B.","role":"aut","family":"Hoyng","display":"Hoyng, Carel B."},{"given":"Nadia","role":"aut","family":"Zakaria","display":"Zakaria, Nadia"},{"family":"Poor","display":"Poor, Stephen","role":"aut","given":"Stephen"},{"given":"Klaus-Peter","role":"aut","display":"Moll, Klaus-Peter","family":"Moll"},{"given":"Deborah","role":"aut","family":"Cosette","display":"Cosette, Deborah"},{"given":"Cecília","role":"aut","display":"Martinho, Cecília","family":"Martinho"},{"role":"aut","given":"Joana","display":"Batuca, Joana","family":"Batuca"},{"family":"Cunha-Vaz","display":"Cunha-Vaz, José","role":"aut","given":"José"},{"role":"aut","given":"Ulrich F.O.","family":"Luhmann","display":"Luhmann, Ulrich F.O."},{"family":"Leal","display":"Leal, Sergio","given":"Sergio","role":"aut"},{"family":"Finger","display":"Finger, Robert P.","role":"aut","given":"Robert P."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 3. Februar 2025","Gesehen am 01.07.2025"],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"April 2025"}],"title":[{"title":"The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration","title_sort":"spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration","subtitle":"a MACUSTAR study report"}],"id":{"doi":["10.1159/000543231"],"eki":["1929396309"]},"name":{"displayForm":["Jan Henrik Terheyden, Frank G. Holz, Charlotte Behning, Hannah M.P. Dunbar, Steffen Schmitz-Valckenberg, Adnan Tufail, Matthias Schmid, David P. Crabb, Marlene Saßmannshausen, Alison Binns, Carel B. Hoyng, Nadia Zakaria, Stephen Poor, Klaus-Peter Moll, Deborah Cosette, Cecília Martinho, Joana Batuca, José Cunha-Vaz, Ulrich F.O. Luhmann, Sergio Leal, Robert P. Finger, on behalf of the MACUSTAR consortium"]},"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen, Diagramme"}],"relHost":[{"pubHistory":["96.1938/39 -"],"origin":[{"dateIssuedKey":"1938","publisher":"Karger","dateIssuedDisp":"1938-","publisherPlace":"Basel"}],"note":["Gesehen am 30.06.25"],"title":[{"title":"Ophthalmologica","title_sort":"Ophthalmologica","subtitle":"international journal of ophthalmology ; journal international d'ophtalmologie ; internationale Zeitschrift für Augenheilkunde ; organ of the Netherlands Ophthalmological Society"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The spectrum of functional, structural, and patient-reported outcomes in intermediate age-related macular degeneration a MACUSTAR study reportOphthalmologica","physDesc":[{"extent":"Online-Ressource"}],"recId":"300897391","id":{"zdb":["1483531-9"],"issn":["1423-0267"],"eki":["300897391"]},"corporate":[{"role":"isb","display":"Nederlands Oogheelkundig Gezelschap"}],"language":["ger"],"part":{"volume":"248","extent":"11","year":"2025","pages":"101-111","issue":"2","text":"248(2025), 2 vom: Apr., Seite 101-111"}}],"recId":"1929396309"} 
SRT |a TERHEYDENJSPECTRUMOF2025